Astex Technology, Cancer Research Technology, GlaxoSmithKline, The Institute of Cancer Research, The Wellcome Trust Ltd. deal

GSK granted licenses to the trust and the institute to three series of small molecule leads that inhibit BRAF to treat cancer. The trust and institute will optimize the leads and isolate candidates. ...